TY - JOUR
T1 - Celiac Disease
T2 - Ten Things That Every Gastroenterologist Should Know
AU - Oxentenko, Amy S.
AU - Murray, Joseph A.
N1 - Funding Information:
Conflicts of interest This author discloses the following: Joseph A. Murray received grant support from Alba Therapeutics and Alvine Pharmaceuticals, Inc, and is a consultant for Entera Health, Inc, AMAG Pharmaceuticals, Sonomaceutials, LLC, and BioLineRx. The remaining author discloses no conflicts.
Publisher Copyright:
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2015/8/1
Y1 - 2015/8/1
N2 - There are 10 things that all gastroenterologists should know about celiac disease (CD). (1) The immunoglobulin A tissue transglutaminase is the single best serologic test to use for the detection of CD. (2) CD can be recognized endoscopically, and water immersion enhances villi detection, although a normal endoscopic appearance does not preclude the diagnosis. (3) It is recommended that 4 biopsies be taken from the second part of the duodenum and 2 bulb biopsies be taken at the 9 o'clock and 12 o'clock positions to maximize the sensitivity for histologic confirmation of CD. (4) Consider serologic testing of first-degree relatives, patients with type 1 diabetes mellitus, Down's, Turner's, and Williams' syndromes, as well as those with premature osteoporosis, iron deficiency, abnormal liver biochemistries, and other manifestations of CD. (5) Patients already on a prolonged gluten-free diet (GFD) should be tested for the presence of HLA DQ2 or DQ8, thereby avoiding the need for further evaluation of CD in non-allelic carriers. (6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry. (8) All patients diagnosed with CD should have clinical follow-up to ensure response and adherence to a GFD. (9) In those with persistent or relapsing symptoms, the robustness of the original diagnosis should be reviewed, gluten exposure sought, and a systematic evaluation for alternative and associated diseases performed. (10) Evaluate those with refractory disease for malignant transformation.
AB - There are 10 things that all gastroenterologists should know about celiac disease (CD). (1) The immunoglobulin A tissue transglutaminase is the single best serologic test to use for the detection of CD. (2) CD can be recognized endoscopically, and water immersion enhances villi detection, although a normal endoscopic appearance does not preclude the diagnosis. (3) It is recommended that 4 biopsies be taken from the second part of the duodenum and 2 bulb biopsies be taken at the 9 o'clock and 12 o'clock positions to maximize the sensitivity for histologic confirmation of CD. (4) Consider serologic testing of first-degree relatives, patients with type 1 diabetes mellitus, Down's, Turner's, and Williams' syndromes, as well as those with premature osteoporosis, iron deficiency, abnormal liver biochemistries, and other manifestations of CD. (5) Patients already on a prolonged gluten-free diet (GFD) should be tested for the presence of HLA DQ2 or DQ8, thereby avoiding the need for further evaluation of CD in non-allelic carriers. (6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry. (8) All patients diagnosed with CD should have clinical follow-up to ensure response and adherence to a GFD. (9) In those with persistent or relapsing symptoms, the robustness of the original diagnosis should be reviewed, gluten exposure sought, and a systematic evaluation for alternative and associated diseases performed. (10) Evaluate those with refractory disease for malignant transformation.
KW - Celiac Sprue
KW - Diagnosis
KW - Genetics
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85028261311&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028261311&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2014.07.024
DO - 10.1016/j.cgh.2014.07.024
M3 - Article
C2 - 25051511
AN - SCOPUS:85028261311
SN - 1542-3565
VL - 13
SP - 1396-404; quiz e127-9
JO - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
IS - 8
ER -